James T. Casper, MD

Hematology/Oncology/Blood & Marrow Transplant

Title(s): Professor, section chief, Medical College of Wisconsin; medical director, Hematology/Oncology, Children's Hospital of Wisconsin.

Education: Medical degree, Medical College of Wisconsin, Milwaukee, 1970; residency, Children's Hospital of Wisconsin, Milwaukee, 1971-1972; fellowships, Milwaukee Blood Center and Children's Hospital of Wisconsin, Milwaukee, 1972-1974.

Certification(s): National Board of Medical Examiners, 1971; American Board of Pediatrics, 1975; American Board of Pediatric Hematology-Oncology, 1976.

Research interests: Pediatric oncology, immunology, stem cell transplant, immunotherapy, immunodeficiency diseases and hematology.

Representative publications:

• Wexler L, Thiele C, McClure L, Chanock S, Mertins S, Tsokos M, Avila N, Reynolds J, Ognibene F, Venzon D, Castleberry R, Casper J, Truitt R, Yannelli J, Schwartzentruber D, Rosenberg S, Horowitz M. Adoptive Immunotherapy (AI) of Refractory Neuroblastoma (NB) with Tumor-Infiltrating Lymphocytes (TIL), Interferon-Gamma (IFN-g) and Interleukin-2 (IL-2). ASCO, 1992.
• Pietryga D, Casper J, Margolis D, Camitta B, Garbrecht F, Drobyski W, Horowitz M, Burns W, Juckett M, Rowlings P, Passweg J, Lawton C, Taylor C, Baxter-Lowe L, Murray K, Pierce K, McAuliffe T, Flomenberg N. Bone Marrow Transplantation (BMT) Using Genotypically Haploidentical Fonors. ASH, 1996.
• Drobyski WR, Horowitz M, Pietryga D, Margolis D, Juckett M, Burns W, Camitta B, Rowlings P, Keever-Taylor C, Casper J. Unrelated Donor Marrow Transplantation for Acute Myelogenous Leukemia (AML), Myelodysplasia, and Secondary AML. ASH, 1996.
• Keever-Taylor CA, Passweg J, Kawanishi Y, Casper J, Flomenberg N, Baxter-Lowe LA. Association of Host-Reactive Cytolytic and Helper T Cells with Outcome Following Alternative Donor T Cell Depleted Bone Marrow Transplantation. ASH, 1996.
• Porter D, Collins R, Mick R, Kernan N, Giralt S, Flowers M, Casper J, Drobyski W, Leahey A, Parker P, Bates B, King R, Antin J. Unrelated Donor Leukocyte Infusions (U-DLI) to Treat Relapse or EBV-Lymphoproliferative Disease (EBV-LPD) after Unrelated Donor Bone Marrow Transplantation (BMT), ASH, 1997.
• Baxter-Lowe LA, Parrish R, Margolis D, Szmania S, Seurynck K, White J, Wank T, Molter M, Hazlett L, Drobyski W, Garbrecht F, Pietryga D, Horowitz M, Camitta B, Vesole D, Burns W, Flomenberg N, Casper J, Keever-Taylor C. HLA Disparity Detected by Automated Nucleotide Sequencing may Aid in Selection of Alternative Donors. ASH, 1997.

Contact information: 8701 Watertown Plank Road, Milwaukee, WI 53226. Phone: (414) 456-4170. Fax: (414) 456-6543. E-mail: jcasper@mcw.edu.